About Dr. Loggie
Dr. Brian Loggie was a surgical oncologist in academia for over four decades. He received his surgical training and completed his residency in Montreal, Quebec, followed by a surgical oncology fellowship in Chicago. He served at Wake Forest University and later at the University of Texas Southwestern Medical Center in Dallas before joining the faculty at Creighton University, where he worked until his retirement in January 2022.
Throughout his distinguished career, Dr. Loggie pioneered the treatment of pseudomyxoma peritonei (PMP). He was instrumental in developing a specialized procedure known as cytoreduction with HIPEC. This treatment involves surgically removing cancerous tissue and heating chemotherapy drugs administered directly into the abdomen. This approach is particularly effective in treating conditions such as peritoneal carcinomatosis and peritoneal mesothelioma.
Dr. Loggie’s Career Highlights
Highlights from Dr. Loggie’s inspiring career include:
- Pioneering heated chemotherapy treatments for peritoneal cancer
- Serving as director of the Cancer Center at Creighton University Medical Center
- Serving as director of the Mesothelioma Applied Research Foundation, developing new and improved treatments for mesothelioma
- Specializing in the treatment and management of rare complex cancers like mesothelioma
“When I started, we had very little treatment. I started an experimental protocol to operate on these patients [and] remove the tumors, [which] always came back after surgery if you didn’t do anything else. So we added heated intraperitoneal chemotherapy as a profusion at the end of surgery, and we were kind of astonished by the results.”
—Dr. Brian Loggie
Dr. Loggie pioneered the use of heated chemotherapy, a technique that can manage or eliminate some complex forms of abdominal cancer, including peritoneal mesothelioma.
“Based on how patients did before that, we weren’t expecting to see very many 1-year survivors, [but we] started seeing 1-, and 2-, and 3-, and 5-year survivors,”
-Dr. Brian Loggie
Although Dr. Loggie is now retired, you can find other top mesothelioma specialists near you using our Free Doctor Match.
Dr. Loggie’s Background
Dr. Loggie earned his medical degree at McGill University in Montreal, Canada, before completing his internship and residency at the Montreal General Hospital.
While a resident, Dr. Loggie also earned a graduate degree from the Department of Experimental Surgery at McGill University. He then completed a Clinical and Research Fellowship in Surgical Oncology at the University of Illinois.
He continued to refine his knowledge and expertise throughout the years, completing several courses and programs, including:
- Specialist Certificate in General Surgery, Royal College of Physicians and Surgeons of Canada
- Certificate of Training in Surgical Oncology, University of Illinois School of Medicine
- General Surgery, American Board of Surgery
Dr. Loggie has held teaching positions at numerous institutes, including the University of Illinois at Chicago, Wake Forest University, and the University of Texas Southwestern Medical Center. He also served as a surgical professor at the Creighton University School of Medicine in Omaha, Nebraska.
While working at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina, Dr. Loggie developed HIPEC, also called heated chemotherapy, which can successfully treat many late-stage abdominal cancers.
Learn how chemotherapy and other treatments helped 7 mesothelioma patients become mesothelioma survivors in our Free Mesothelioma Survivors Guide — packed with tips and advice on beating your diagnosis.
Medical Specializations
Throughout his multi-decade practice, Dr. Loggie focused on treating rare and aggressive cancers, including tumors and mesothelioma.
He was especially known for developing effective management and treatment plans for patients with late-stage cancer. Dr. Loggie also specialized in HIPEC, a highly effective mesothelioma treatment procedure.
Our Free Doctor Match can help you find top mesothelioma specialists who can customize your treatment plan.
Dr. Loggie’s Career Accomplishments
Dr. Loggie is renowned for developing heated chemotherapy, a groundbreaking procedure successfully treating peritoneal mesothelioma and advanced abdominal cancers.
Most of Dr. Loggie’s patients were referred to him after receiving a bleak prognosis from other medical facilities, and his heated chemotherapy has saved the lives of many of them. In addition to treating patients with terminal cancers, Dr. Loggie has helped many of them extend their life expectancy by five or more years. His patients have reported significant improvements in their overall health and wellness, even if their cancer was not fully eradicated.
Dr. Loggie has been a fervent advocate for patients with rare types of cancer, raising awareness and funding for oncology research in often overlooked areas. He has consistently prioritized the quality of life of his patients above all else.
Awards & Honors
Dr. Loggie’s awards and honors include:
- Best Doctors in America (peer selected)
- Castle Connoly’s America’s Top Doctors
- CMS Meaningful Use Stage 1 Certification
- Dr. Harold J. Bonnstetter Endowed Chair in Preventive Medicine
- Magis Award from Creighton University
Professional Affiliations
Dr. Loggie is also a member of several professional societies and organizations, including:
- Director, Mesothelioma Applied Research Foundation
- Fellow, American College of Surgeons
- Fellow, Royal College of Surgeons of Canada
- Fellow, Society of Surgical Oncology
- Member, International Society for Regional Cancer Therapy
- Member, American Society of Clinical Oncology
- Member, Association for Academic Surgery
Connect with a top mesothelioma doctor near you — use our Free Doctor Match.
Notable Works by Dr. Loggie
Dr. Loggie has made massive contributions to the peritoneal mesothelioma treatment landscape. In 2001, Dr. Loggie published his results from a prospective trial that studied this new therapy to treat peritoneal mesothelioma.
The trial aimed to test the effectiveness of cytoreduction (tumor-debulking) surgery in combination with heated chemotherapy, a therapy now known as cytoreduction with HIPEC. Dr. Loggie conducted this treatment approach on multiple patients.
Following the cytoreductive surgery, which removed as many tumors as possible, Dr. Loggie administered heated chemotherapy drugs directly into patients’ abdominal cavities for two hours.
The vast majority of patients involved in this trial significantly improved their survival time. When Dr. Loggie published his results, one patient had already remained cancer-free for five years. Though novel, this approach has become a standardized and highly effective treatment for patients with peritoneal mesothelioma.
Research
Dr. Loggie was highly active in research, with publications in esteemed medical journals such as the “Archives of Surgery” and “Annals of Surgical Oncology.” His research topics often revolved around innovative treatments like intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. He was the Principal Investigator for NIH Grant #1 RO1 CA67809-01 from 1995-1998, focused on “Surgically Directed Hyperthermic Chemotherapy,” among other funded projects.
Connect With Other Top Mesothelioma Specialists
We can help you connect with top mesothelioma doctors who provide life-extending treatment for patients nationwide.
Use our Free Doctor Match to begin your treatment journey.
